Financial-condition grades for SEC filers
Company Report · as of Oct 9, 2026
|
| SS Innovations International, Inc.SSII · healthcare | |
|---|---|
| Grade | Nonecomputable_factors_below_threshold: 5 of 14 inputs computable; 7 are required |
| Reliability | 0.83 AUCfailure model, filers with $12.5M to $120M assets; 95% interval 0.79 to 0.86; 201 events, 2020 to 2025 |
| Peer failure rate | 1.07% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025 |
| Size band | $12.5M to $120M assetstotal assets $74.2M[1] |
| Standard universe | insiderevenue above $1M and assets above $10M[1-2] |
| Warnings | late filer, thin data · fortress balance sheetnot computable: dilution, distress |
| Inputs computable | 5 of 14 |
| Graded from | filings received through Mar 31, 2026192 days before the rescan; every figure keyed to the SEC receipt date |
| Last close | $2.692026-10-08; market equity $538.0M; iex feed |
| Price used in grade | None |
| Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date. Open this report as it stood on | ||||||||||||||||
Each date opens the report as it stood on that rescan. |
Business, in the company's words. Opening of Item 1 of the 10-K received Mar 10, 2026; the document on sec.gov.
management for future operations, including plans or objectives relating to the marketing of our surgical robotic systems; (ii)the timing or likelihood of regulatory filings, approvals and required our intellectual property rights and enforce such rights to avoid violation of the intellectual property rights of others; (iv)the timing, costs and other aspects of the commercial marketing of our surgical market opportunity, clinical utility, potential advantages and market acceptance of our surgical robotic systems; have on our ability to import our surgical robotic systems and related devices into the U.S., once approval to market has been obtained; our ability to recruit and retain qualifi...
7 checks ran; none of them enters the letter. The checks are listed on the warnings screen.
Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.
| Input | Percentile, 0 to 100 | Value | Source | Peer median | Percentile | Peers | Period end |
|---|---|---|---|---|---|---|---|
| Profitability, sleeve percentile 72.8 | |||||||
| Gross profitability | 26.3% | [1,5] | 32.2% | 54.2 | 372 | 2025-12-31 | |
| Return on invested capital | not computable | 9.3% | |||||
| required facts have no common fiscal period end | |||||||
| Accruals ratio | 11.0% | [1,6-8] | (6.6%) | 91.5 | 811 | 2025-12-31 | |
| Gross margin stability, five years | not computable | 2.8 pts | |||||
| five annual gross margins are required; found 3 | |||||||
| Solvency, sleeve percentile 55.6 | |||||||
| Twelve-month failure probability | not computable | 0.07% | |||||
| latest liabilities, cash plus short-term investments, book equity, and shares are required | |||||||
| Altman Z double-prime | (0.08) | [1,9-14] | (0.31) | 37.0 | 756 | 2025-12-31 | |
| Net debt to EBITDA | not computable | 1.82x | |||||
| EBITDA must exceed $100,000 | |||||||
| Interest coverage | not computable | (4.51x) | |||||
| latest aligned inputs end 2023-12-31; latest annual assets end 2025-12-31 | |||||||
| Current ratio | 1.86x | [9-10] | 2.96x | 74.2 | 839 | 2025-12-31 | |
| Growth and financing, sleeve percentile 1.7 | |||||||
| Revenue growth, three-year compound | not computable | 10.0% | |||||
| four annual observations are required; found 3 | |||||||
| Free cash flow growth, three-year compound | not computable | 10.9% | |||||
| four consecutive annual FCF observations are required; found 3 | |||||||
| Reinvestment rate | not computable | 37.1% | |||||
| pretax income must exceed the validity floor and imply a 0%-100% tax rate | |||||||
| Asset growth, three years | 119.9% | [1,8,15-16] | 2.1% | 1.7 | 704 | 2025-12-31 | |
| Net share issuance, one year | not computable | 2.5% | |||||
| raw and split-adjusted prices do not align at 2025-04-14 | |||||||
Gross profitability. Revenue less cost of goods sold, over total assets.
Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.
Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.
Twelve-month failure probability. CHS model; lower is stronger.
Net debt to EBITDA. Lower is stronger.
Net share issuance, one year. Split-adjusted; lower is stronger.
Market measures at the 2026-10-08 close. None enters the grade. Percentile among graded peers with the same measure.
| Measure | Value | Peer median | Percentile | Reading |
|---|---|---|---|---|
| Twelve-month price change, skipping the latest month | (47.5%) | 8.0% | 15 | hotter than 15 of 100 peers |
| Distance from 52-week high | (73.6%) | (31.4%) | 11 | closer to its high than 11 of 100 peers |
| EBIT to enterprise value | not computable | (1.5%) | required accounting or market input is missing | |
| Free cash flow yield | (4.2%) | (1.0%) | 42 | pricier than 58 of 100 peers |
| Book value to price | 0.10 | 0.28 | 25 | pricier than 75 of 100 peers |
| Sales to price | 0.08 | 0.31 | 22 | pricier than 78 of 100 peers |
| Composite equity issuance, five years | not computable | 20.3% | a share count from five years earlier is required | |
| Relative strength against the sector, log excess return | (0.86) | (0.14) | 15 | ahead of 15 of 100 peers |
Inputs: market equity $527.0M; EBIT -$8.2M; free cash flow -$22.2M; book equity $53.4M; sales $42.5M; cash $13.6M[17].
Diagnostics do not feed the grade.
| Piotroski F-score: None of 9, period end 2025-12-31 | ||
|---|---|---|
| Return on assets above zero | (28.6%) | ✗ fail[6,8] |
| Operating cash flow above zero | -$18.5M | ✗ fail[7] |
| Return on assets improved | 32.2 pts | ✓ pass[6,8,15,18] |
| Operating cash flow exceeds net income | -$6.4M | ✗ fail[6-7] |
| Long-term leverage fell | n/a[1,8,15] | |
| Current ratio improved | 57.4 pts | ✓ pass[9-10,19-20] |
| No new shares issued | n/a[21-22] | |
| Gross margin improved | 5.1 pts | ✓ pass[2,5,23-24] |
| Asset turnover improved | 34.7 pts | ✓ pass[2,8,15,24] |
| Cash, filings, liquidity | |
|---|---|
| Cash and equivalents | $13.6M[25] |
| Operating cash flow, four quarters | -$15.5M[7,25-29] |
| Months of runway | 10.5 |
| Late filings, two years | 1 |
| NT 10-K or NT 10-Q | |
| Days since last periodic filing | 57 |
| 10-Q received Aug 13, 2026 | |
| Median daily dollar volume | $165,657 |
| 63 sessions | |
| Days since newest grade input | 192 |
|
Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.
| # | Concept | XBRL tag | Value | Period end | Received | Form | Links |
|---|---|---|---|---|---|---|---|
| 1 | assets | us-gaap:Assets | $74.2M | 2025-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 2 | revenue | us-gaap:Revenues | $42.5M | 2025-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 3 | cash | us-gaap:CashAndCashEquivalentsAtCarryingValue | $2.0M | 2023-12-31 | 2025-04-15 | 10-K | filing · viewer · series |
| 4 | total debt | us-gaap:LongTermDebt | $510,189 | 2023-12-31 | 2024-12-20 | 10-K/A | filing · viewer · series |
| 5 | gross profit | us-gaap:GrossProfit | $19.5M | 2025-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 6 | net income | us-gaap:NetIncomeLoss | -$12.1M | 2025-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 7 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$18.5M | 2025-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 8 | assets | us-gaap:Assets | $42.4M | 2024-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 9 | current assets | us-gaap:AssetsCurrent | $48.8M | 2025-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 10 | current liabilities | us-gaap:LiabilitiesCurrent | $26.2M | 2025-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 11 | retained earnings | us-gaap:RetainedEarningsAccumulatedDeficit | -$55.8M | 2025-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 12 | operating income | us-gaap:OperatingIncomeLoss | -$8.2M | 2025-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 13 | book equity | us-gaap:StockholdersEquity | $38.2M | 2025-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 14 | liabilities | us-gaap:Liabilities | $36.0M | 2025-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 15 | assets | us-gaap:Assets | $31.5M | 2023-12-31 | 2025-04-15 | 10-K | filing · viewer · series |
| 16 | assets | us-gaap:Assets | $7.0M | 2022-12-31 | 2024-12-20 | 10-K/A | filing · viewer · series |
| 17 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 200,385,435 | 2026-08-12 | 2026-08-13 | 10-Q | filing · viewer · series |
| 18 | net income | us-gaap:NetIncomeLoss | -$19.2M | 2024-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 19 | current assets | us-gaap:AssetsCurrent | $27.4M | 2024-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 20 | current liabilities | us-gaap:LiabilitiesCurrent | $21.3M | 2024-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 21 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 200,231,535 | 2026-03-09 | 2026-03-31 | 10-K/A | filing · viewer · series |
| 22 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 193,559,340 | 2025-04-14 | 2025-04-15 | 10-K | filing · viewer · series |
| 23 | gross profit | us-gaap:GrossProfit | $8.5M | 2024-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 24 | revenue | us-gaap:Revenues | $20.6M | 2024-12-31 | 2026-03-10 | 10-K | filing · viewer · series |
| 25 | cash | us-gaap:CashAndCashEquivalentsAtCarryingValue | $13.6M | 2026-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
| 26 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$6.5M | 2026-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
| 27 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$2.3M | 2026-03-31 | 2026-05-13 | 10-Q | filing · viewer · series |
| 28 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$17.0M | 2025-09-30 | 2025-10-28 | 10-Q | filing · viewer · series |
| 29 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$9.6M | 2025-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.
Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.
Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.
Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.
Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.